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Abstract: 
Protein engineering and synthetic biology stand to benefit immensely from recent advances in in 
silico tools for structural and functional analyses of proteins. In the context of designing novel 
proteins, current in silico tools inform the user on individual parameters of a query protein, with 
output scores/metrics unique to each parameter. In reality, proteins feature multiple 
‘parts’/functions, and modification of a protein aimed at altering a given part, typically has 
collateral impact on other protein parts. A system for prediction of the combined effect of design 
parameters on the overall performance of the final protein does not exist.  
Function2Form Bridge (F2F-Bridge), attempts to address this by combining the scores of different 
design parameters pertaining to the protein being analysed into a single easily interpreted output 
describing overall performance. The strategy comprises 1. A mathematical strategy combining 
data from a myriad of in silico tools into an OP-score (a singular score informing on a user-defined 
overall performance); 2. The F2F-Plot, a graphical means of informing the wetlab biologist 
holistically on designed construct suitability in the context of multiple parameters, highlighting 
scope for improvement.  
F2F predictive output was compared with wetlab data from a range of synthetic proteins designed, 
built and tested for this study. Statistical/machine learning approaches for predicting overall 
performance, for use alongside the F2F plot, were also examined. Comparisons between wetlab 
performance and F2F predictions demonstrated close and reliable correlations. 
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This user-friendly strategy represents a pivotal enabler in increasing accessibility of synthetic 
protein building and de novo protein design.      
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INTRODUCTION 
The world of in silico aided protein design Proteins are multi-functional biomolecules that 
perform, mediate and regulate various fundamental functions of life. Over the last 50 years our 
understanding of proteins and our ability to engineer them has improved dramatically. While 
proteins find their applications in various fields, biochemical and medical applications have taken 
the driving seat commercially. Since 1982, when insulin, the first recombinant protein was 
produced the biotechnological way, the market value for protein-based therapeutics has seen a 
significant increase, with the market value of bioengineered protein drugs is expected to reach 
$336.9 billion by 20251,2. Nature has sampled only a small fraction of the theoretical combinations 
of amino acids that are accessible to proteins3 , due to the constraints put in place by evolution. 
Synthetic protein design represents a vast sea of possible space available to be explored. While 
multiple industries have the potential to exploit non-natural proteins as components of their 
products or processes, this potential cannot be fully realised without reliable control over protein 
design.  
Understanding the interplay between structure and function of proteins is pivotal in protein design. 
Techniques such as NMR spectroscopy and X-Ray Crystallography have revealed the structures 
of over 100,000 proteins and have aided the establishment of protein databases4, which in turn 
have facilitated in silico protein structure and function prediction based on the amino acid 
sequence. The need for a faster and affordable way to predict the putative structure of a protein 
paved the way for computational protein modelling5. In silico-aided protein design uses 
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computational strategy for designing and building proteins that perform a specific function(s), in 
a user defined setting. Computational methods for structure modelling, docking and function 
prediction provided in silico alternatives for screening protein sequences, creating variants of a 
specific design6 and building new de novo structures (Figure 1 in silico tools) 7. As a consequence 
of increasing computational power, the power of in silico protein structure and function prediction, 
and analysis tools is expanding rapidly.  
      
Figure 1:  
 
The overall performance problem: Multiple related parameters and the myriad of in silico tools 
Computational tools are now available to predict protein structure, active sites, chemical properties 
and interactions with other proteins8-12. In some cases, these tools could also be used to redesign 
existing proteins13 or even design entirely new proteins, in the rapidly evolving field of de novo 
design14-17. Unfortunately, a side effect of these rapid advances is that, it is becoming difficult to 
bridge the gap between these advances in computational technology and their originally intended 
wetlab applications by biologists. ‘Outsourcing’ the required in silico activity by end users (wetlab 
biologists) entirely to ‘dry-lab’ specialists dramatically reduces the potential of in silico modelling, 
‘User empowerment’ is key to translating this potential. 
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Designing a protein involves defining an overall function (Box 1) and associating it with a 3D 
structure which is coded into an amino acid sequence18. In most cases, the overall function of a 
protein is a combination of several individual sub-functions. To achieve the overall function, 
fusing different sub-function parts (Box1) has been the most popular strategy to date. In recent 
years, de novo protein design has been used to obtain amino acid sequences which fold into a 
required 3D structure for a defined function. In both of these cases, several test sequences are 
generated to validate their performance against the defined overall function. In silico protein 
design aims to find a ‘best-fit’ test sequence for a defined overall function (Figure 2).  
 
Box 1: Definitions and commonly used terms 
 
Overall performance: The degree to which the designed protein would perform the defined 
Overall Function 
 
Sub-function part: A part of a protein that is responsible for a particular sub-function. A Sub-
function part may represent a sequence for a specific known protein or a part of a protein which 
has a defined distinct function. 
 
Design Parameters: Parameters such as hydrophobicity, solubility, structure, active site 
exposure etc., influence the overall performance of a protein. While these parameters are tools 
for studying the nature of existing proteins, the same parameters, in protein design, can be used 
as controllers to dictate the overall performance of a protein. Such parameters that dictate the 
overall performance of a designed protein are grouped under an umbrella term called ‘design 
parameters’.  
 
The overall performance prediction problem: The complex relationship between the 
interconnected design parameters and the overall performance. 
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The overall performance of a test sequence is a collective functioning of all the individual sub-
function parts in concordance. In most cases, the quality of the functioning of the individual sub-
function parts is interdependent. Wetlab validation of each test sequence is time consuming, labour 
intensive and expensive. Moreover, improving a given sequence by modifying individual 
subfunction part sequences without a holistic analysis on the overall performance represents an ad 
hoc approach prone to low success rates.  
      
Figure 2: 
Computational tools are now available to predict protein structure, active sites, chemical properties 
and interactions with other proteins. These tools score and inform the quality of the individual 
design parameter using their respective conventional metrics. While these metrics define the 
quality of the individual parameter in the design, the combined effect of the design parameters 
(Box 1) on the overall performance is a question yet to be answered. We termed this as ‘the overall 
performance problem’ (Box 1). The overall performance problem is a huge challenge in biology 
wetlab experimentation but not completely new in a mathematical perspective. Recent advances 
in machine learning and data analyses have solved similar situations. For example, ‘selecting a 
suitable house in a new city’ or ‘selecting an electronic device that fits my purposes’ and ‘selecting 
a car appropriate to my needs and budget’. All these situations are mathematically similar to an 
extent. The parameters affect the overall performance and the best fit is chosen based on scoring 
and ranking the potential fits, based on the user’s needs. Although the overall performance problem 
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has been addressed in other contexts, in the scientific field of protein design, formulating a 
mathematical model poses a greater challenge. This is due to (i) the lack of a reporting system for 
negative results, (ii) time constraints in biological experimentation and (iii) the lack of 
standardization of measurement units in many areas of biological research. 
 
In this work, we propose F2F-Bridge as a novel mathematical strategy aimed at predicting the 
overall performance of a synthetic protein. Several test sequences were designed for a defined 
overall function. The individual scores for all the different design parameters pertaining to each 
test sequence are condensed into a graphical output. The result is a visual and numerical evaluation 
of the test sequence. The graphical output (F2F-Plot) and the numerical evaluation (OP-score) 
together form a novel mathematical strategy (F2F-bridge) that scores, ranks and predicts the 
overall performance of the given set of test sequences. This method combines user input with in 
silico data to give insights into the predicted overall performance of a test sequence. With the view 
to eventually developing a robust tool for protein performance prediction, we also examined 
relationships between in silico and laboratory data for test proteins using two different strategies 
for feature selection and predictive model building: LASSO and regression-based decision trees 
implemented with the RandomForest algorithm. 
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MATERIALS AND METHODS 
In silico design of test sequences: 
Luminescence proteins: Each construct was designed to have a luminescent domain, a 
binding domain, a solubility tag and a secretion signal. All parts are linked in all possible 
permutations using different rigid and flexible linker sequences19 (Figure 3). Variable heavy and 
light chain AA sequences from different antibodies were used as the binding domains, from an 
antibody targeting either cell surface associated epithelial mucin 1 (MUC1; mammalian antigen) 
or Clumping factor A (ClfA) of Staphylococcus aureus (bacterial antigen). Test sequences were 
designed to bind to their respective target and present luminescence as a readout (bound protein 
luminescence). Fluorescence proteins (used for further validation) are described in Supplementary 
Text 3. 
      
      
Figure 3:  
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The different in silico features analysed in relation to the overall performance of the test protein, 
and how they are generated is outlined in Table 1, with more detailed instructions found in 





The data described in the data generation stage were taken as input into the Function2Form 
function, written in the R programming language. The F2F function takes as input a data frame 
with all proteins to be screened as rows, and the different in silico observations as columns. The 
first row of the table contains a set of user desired input values. Some of these are based on the 
benchmarks provided by in silico programmes such as RC score and Instability, while in other 
cases the user can specify the ideal needs for the protein (e.g. hydrophobic and < 30 kDa). The 
features used in this study are detailed in Table 1, but the F2F-Bridge function is not limited to 
these and can be easily expanded or condensed depending on individual user requirements. 
The test sequences are then screened by the function and the output is a data frame of the test 
sequences and their respective scores, along with a radar plot for each test sequence, highlighting 
the differences between each sequence and the input parameters as can be seen in Figure 5. Areas 
where the candidate protein does not meet the preset requirements will appear outside the coloured 
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region of the reference values. As well as this visual analysis of the suitability of the protein, a 
score indicating overall function is provided. The OP score is the grand average of absolute 
distance between each particular feature of the protein, and the user-specified/program specified 
reference range. For cases of high throughput in silico screening, an additional function allows the 
user to extract the n top scoring test sequences from the overall selection.  
 
F2F R function:  
Generating the OP score 
(i) Where possible, convert different in silico observations to same scale 
𝑖𝑖 = �
(𝑂𝑂 −  𝑂𝑂𝑚𝑚𝑚𝑚𝑚𝑚)
(𝑂𝑂𝑚𝑚𝑚𝑚𝑚𝑚 −  𝑂𝑂𝑚𝑚𝑚𝑚𝑚𝑚)
� ∗  (𝑁𝑁𝑚𝑚𝑚𝑚𝑚𝑚 −  𝑁𝑁𝑚𝑚𝑚𝑚𝑚𝑚) + 𝑁𝑁𝑚𝑚𝑚𝑚𝑚𝑚 
Where O is the old range and N is the new range, which in the case of the F2F function is always 
0-100.  
(ii) F2F function then iteratively scores each test sequence supplied in input table 




Where x is the test sequence to be scored, y is the set of reference values, i refers to the ith 
observation within the in silico data table supplied to the algorithm, and n is the total number of 
observations i.  
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Generating the F2F plot 
Figure 5 shows the graphical output of the F2F function. Each sequence tested is assigned an OP 
score as discussed above, and a radar plot is generated. For every in silico observation provided in 
the input data, an axis is created on the radar plot. This enables the user to see which specific in 
silico feature or features are making the test sequence unfit for purpose. 
 
Statistical and Machine learning methods: 
Two other methods of transforming the in silico data into a prediction of overall performance were 
assessed. The aim was to examine the data for relationships of any kind between the predictive 
features and the wet lab output with the view to either design a system of weights for the predictive 
features to improve the F2F plot, or to create a new predictive tool to be used in conjunction with 
the F2F Bridge.  
i) LASSO Feature selection and subsequent generation of predictive models can be used in 
conjunction with the F2F-Bridge programme. LASSO regression puts a constraint on the sum of 
the absolute values of the model parameters, which must be less than a fixed upper limit. It does 
this by applying a regularisation process (shrinkage) where it penalizes regression coefficients and 
shrinks a selection to zero. Variables that still have a non-zero coefficient after the shrinking 
process are selected to be part of the final model 20 . 
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ii) TREE BASED METHOD The second method was to use a regression tree as per the random 
Forest package in R to generate a variable importance plot, again using the in silico parameters as 
input, and wetlab luminescence as the indicator of overall performance. An outline of how random 
forest works in generating these regression trees is as follows. A predefined number of 
bootstrapping samples are drawn from the original data. For each of these samples, an “un-pruned” 
regression tree is grown. Traditionally, the best split at each node to differentiate all predictors 
would be used, but in this instance the best split is found amongst a random subset of the predictors. 
Following this, predictions are made by aggregating the predictions of the pre-defined number of 
trees and taking the average value21. The quality of the model was ensured by finding the optimal 
number of features to randomly sample at each split, and to ensure that enough iterations of the 
model are run to ensure that the out of bag error has stabilised.  
      
Wetlab validation: 
The luminescence test synthetic proteins examined are outlined in Figure 3. Two biological facets 
were used to assess the effectiveness of the functional prediction strategies – i) binding; ii) 
secretion. Sub-function parts on the test sequences include: (i) Active site: Heavy and light chains 
of anti-MUC1 antibody (C595) and anti-ClfA antibody were fused with EAAAK (rigid) and 
GGGGS (flexible) linkers to obtain Monospecific bivalent diabodies and Monovalent ScFVs 
(monobodies), (ii) Secretion signal: Gaussia luciferase’s native secretion signal, (iii) Solubility 
enhancer: SUMO tag, (iv) Reporter: Truncated version of Gaussia luciferase was used as a 
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luminescence reporter. (v) Detection tag: Flag peptide was used as a detection tag for downstream 
assays. See Fig 4. 
Presence or absence of certain sub-function parts or their design orientation has a significant effect 
on the overall performance of the protein and should be accounted carefully in the design phase. 
In our case, over 50 different amino acid sequences were designed against each target. Of these, 8 
variants per target were synthesised for testing in the wetlab. These test sequences vary in (a) (+/-
) solubility enhancer, (b) (+/-) and positioning of Active site and (c) the type/format of Active site. 
All these test sequences were tested for their overall performance. Wet lab data were used to 
validate and improve the results from the F2F-Bridge. An outline of the laboratory workflow can 
be seen in Figure 4, and a more detailed description on synthesis and build of ‘test sequences’ can 
be found in Supplementary Text 3. 
Wetlab analysis of fluorescence test sequences is described in Supplementary Text 3. 
 
Data generation from wetlab experiments with luminescence proteins: 
Binding assays: 108 Staphylococcus aureus TCH959 (naturally bearing clfA) or 106 MCF7 cells 
(naturally bearing MUC1) were blocked with 5% BSA for 2 h followed by incubation with 
supernatant containing each test construct. Cells were washed 3 times and resuspended in PBS. 
Luminescence was measured using Promega GloMax® 96 luminometer. In our case, since bound 
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luminescence is the overall function, the luminescence readings corresponding to each test 
sequence are recorded and used for validating and improving F2F Bridge. 
      
Figure 4:  
 
Statistical analysis: All statistical testing, unless otherwise stated, was performed in the base R 
environment v3.4.322. The LASSO regression feature selection method was implemented using 
the Glmnet library v2.0-1623, and the Random Forest regression tree analysis was performed using 
the RandomForest library v4.6-1424. The radar plot within the F2F-bridge function was 
implemented with the fmsb library, v0.6.325. Visualisation was carried out using the ggplot2 
package,v3.1.126. 
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RESULTS 
Overall Biological Performance - Bound luminescence 
16 test AA sequences were scored using F2F-plot. The result of F2F-plot analysis and associated 
scores for all test sequences can be seen in Figure 5 and Supplementary Figure 1, and a detailed 
workflow of the strategy can be found in Supplementary Text 2, additionally the raw data can be 
found in Supplementary Table 1. It can be seen from the output of the F2F-bridge that the ClfA 
Monobody 2 test sequence (represented by the pink shaded region) has an instability index score 
that is far higher than the user required level (blue shaded region), but there is minimal difference 
between the different shaded regions across the other axes, which contributes to ClfA Monobody 
2 having a low and therefore good score. The test sequence predicted to have the poorest overall 
performance, ClfA Diabody 2, has levels of solvent accessibility and docking affinity that are much 
lower than required, as well as an increased instability index. These factors combine to give this 




These sequences were used to generate the corresponding proteins as outlined in the Methods 
section. Biological performance of these proteins was assessed in the wetlab using binding assays 
with luminescence as the readout, corresponding to Overall Performance.  
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Table 2 shows the results (Wetlab – luminescence units; F2F – OP score) of all test sequences 
whose biological performance was predicted with F2F-Bridge. The accuracy of F2F prediction 
was assessed by comparing the F2F-prediction of overall biological performance with the 
laboratory luminescence data.  
Overall, the correlation pattern showed the F2F-Bridge method providing a general guide for how 
the test sequence can be expected to perform. In a database of this limited size, there was no 
statistically significant correlation between the OP-score and the ‘bound protein luminescence’ 
evident. This was repeated with ‘luminescence’ as the wet lab output, but again there was no 
relationship present (Data not shown). 
 
Investigation of alternative methods to complement F2F plot 
1) LASSO Regression 
‘Bound luminescence’ as overall performance: The output of Lasso analysis of the test sequences 
for bound protein luminescence can be seen in Figure 6. In the case of test sequences against 
MUC1, the features deemed to have the most effect on bound protein luminescence were Docking 
Affinity, Hydrophobicity, Solvent accessibility and Isoelectric point. However, when these 
predictive features were input into a linear model, no linear relationship was detected. The same 
was found when analysing the potential relationship between the test sequences against ClfA and 
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their eventual bound protein luminescence. In this case, Hydrophobicity and Instability were the 
features selected, and again, no linear relationship was found.  
Despite the LASSO method detecting possible relationships between the predictive features and 
the test variable (bound protein luminescence), no predictive linear model could be constructed 
(Table 3). We speculate that there may be too many variables present from a wetlab perspective 
for us to accurately predict bound luminescence with a database of this size. 
 
‘Secreted luminescence’ as overall performance: To counter this, we also examined 
‘luminescence’ only resulting from protein secretion as a measure of overall biological 
performance. As we are just measuring the degree of luminescence of the test sequences, and not 
their binding to a target, the two groups (antiMUC1 and antiClfA) can also be directly compared, 
doubling our sample size. Figure 6 uses the LASSO method to investigate the relationship between 
in silico observations and luminescence due to secretion of anti–Clfa test sequences. In silico 
observations implicated in dictating the level of secretion of a test sequence were identified by 
LASSO. These were then used to generate a linear model to examine the degree to which they 
explained the luminescence due to secretion of the test sequences. This gave a linear model that 
explained 84.6% of the variability in luminescence of all test sequences, with an associated p-value 
of 0.004. This led us to explore the utility of a LASSO dictated linear model as a predictive tool. 
The luminescence levels predicted by the model were correlated with the experimentally 
determined luminescence levels. This, and also correlation coefficients of individual test sequence 
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groups against their luminescence, are shown in Figure 6, and numerically in Table 4. As would 
be expected, antiClfA test sequences which are the training set, show stronger correlation (Rho 
0.93), but that of the antiMUC1 test sequences was also significant. 
  
      
2) Alternative methods for prediction of test sequence performance; Random Forest 
Regression Tree analysis 
The same methodology was used for a regression tree implemented within random Forest. The 
test sequences against ClfA were used as the training data set, and the test sequences against 
MUC1 test sequences were used as the test set. The regression model derived from the random 
forest algorithm was able to explain 41% of the variability in the luminescence of the training set 
data test sequences (Figure 6). The values predicted by random forest for luminescence for the 
individual proteins were then correlated with their experimentally derived levels of luminescence 
(Table 5). This method showed a significant correlation between the luminescence values 
predicted by the random forest algorithm, and the experimental values. Random forest regression 
analysis was carried out with bound protein luminescence as the wet lab output, but no 
significant results were found (data not shown). 
 
Figure 6:  
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We postulate that with an increased amount of data available for training the models, this accuracy 
can only increase. A summary of all the tests performed and their outcomes is shown in Table 6. 
 
Further Validation – Fluorescence Proteins 
The F2F plot was further validated on a second dataset of 8 test sequences and resulting laboratory 
data (fluorescence readings from proteins). In this instance there was no need for the secondary 
functionality of feature selection and model building based on a subset of the data, as the OP score 
predicted showed a statistically significant inverse correlation with overall performance of the test 
sequence. These results are presented in Figure 7 and Table 7, and the accompanying F2F plots, 
scores and raw data are shown in supplementary Figure 2 and Table 2. In this case, fluorescence 
was the overall function of the 8 test sequences to be predicted. Unlike the dataset discussed 
previously, in this case, the F2F-plot predicted scores showed a strong inverse correlation with the 
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DISCUSSION 
In this study, we have shown how F2F plot could help to visualize the overall performance of a 
test sequence, particularly if complemented by the statistical methods examined. For each 
sequence, the OP score predicts the expected efficacy, and the F2F plot provides a graphical 
overview of predicted strengths and weaknesses. Unlike the pre-existing in silico tools that inform 
the quality of individual design parameter, F2F bridge takes a top down approach on overall 
performance by predicting the collective influence of all the design parameters on given test 
sequence. Such a holistic outlook on the overall performance holds a key for informed protein 
design. F2F bridge could be used either for low throughput design (see Table 8), accounting for 
the ‘pitfalls and merits’, in the design corresponding to a particular test sequence, or for high 
throughput in silico screening by comparing and ranking a set of test sequences.  
By informing the end user (wet lab biologist) with performance predictions, F2F plot and OP score 
together aim to ultimately bridge the gap between easily generated, seemingly abstract in silico 
values, and experimental results. 
When combined with downstream testing, we have shown that patterns exist in the easily generated 
in silico data that can be used to generate predictive models. 
F2F Bridge An unweighted and unsupervised combination of features deemed likely to have an 
effect on biological performance showed promising results. The F2F-Bridge is able to give an 
early indication of the expected performance of a test sequence. Given the ease of implementation, 
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in comparison with wetlab experiments, any information provided about candidate test sequences 
prior to synthesis is extremely valuable. As well as the OP-score provided, the accompanying radar 
plot can also highlight any design aspects of the test sequence that diverge from what is required 
as per the user input parameters. We expect a considerable improvement in performance of both 
the F2F-Bridge and associated models, with an expanded dataset, in the meantime further work to 
refine or build on the method was carried out.   
Feature selection driven linear models with LASSO LASSO regression was used to search for 
patterns in the data that could help predict the level of luminescence due to a test sequence binding 
to its target. Features that have an effect on bound luminescence were identified. When viewing 
the plots of normalised Lambda1 vs coefficients, what is important is the point at which the 
predictive feature enters the model, and the effect it has on the dependent variable. In this case, it 
was impossible to incorporate them into a statistically significant linear model to predict any of 
the variability in bound protein luminescence. We speculate that, with a database of this small size, 
there were too many different processes involved from a laboratory perspective for the strategy to 
accurately predict the final outcome (steps in cell expression of a given test sequence, protein 
binding to target, luminescence production). For this reason, and the opportunity to increase the 
sample size, we also analysed the secreted luminescence data. This was much more successful in 
terms of improving on the F2F-Bridge.  
LASSO regression-based feature selection was used again, to look for patterns between in silico 
observations of the antiClfA test sequences and their experimentally determined secreted 
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luminescence 20 . This was more effective. We have shown that a linear model can be predicted 
using LASSO feature selection that can predict values for luminescence that correlate strongly 
with experimentally determined values. This functioned retrospectively to find patterns between 
in silico features of antiClfA test sequences and their eventual levels of secreted luminescence, it 
can also function prospectively. Once the linear relationship between a subset of the in silico 
features and luminescence has been established for antiClfA, this was used to successfully predict 
luminescence values in a test set of antiMUC1 proteins which correlated with the experimental 
values. The antiMUC1 data originated from a different experiment, and a different class of proteins 
to the antiClfA test sequence training set, so the fact that the linear model still has predictive power 
is extremely encouraging.   
Random Forest regression trees The random forest regression tree model, given the same in 
silico features as the LASSO regression, was able to explain ~41.01% of the variability in secreted 
luminescence within the antiClfA test sequence dataset. The predicted secreted luminescence 
values generated by the regression tree model significantly correlated with the experimentally 
derived secreted luminescence values. On a group by group basis, it is extremely encouraging that, 
as with the LASSO based method previously, a random forest regression model trained on the 
antiClfA test sequences was then able to predict luminescence for the test set (antiMUC1 test 
sequences) that correlated significantly with the values derived experimentally 21. Future work, 
with an expanded database would involve assessing whether these associations identified with the 
two above methods become stronger as the database size increases, and also, if this method of 
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predicting overall biological performance holds true for other tasks, opening up the possibility of 
the design of an accurate prognostic tool for test sequence performance.  
Relevance to the laboratory scientist It is important to frame these results in the context of the 
difference in cost between in silico- and laboratory-based screening. In silico screening requires a 
fraction of the time, money or expertise of laboratory-based screening, so maximising the value of 
this data can lead to considerable operational savings. Wet lab experimentation is often a prolonged 
process in biological research. In most cases, the data from wetlab assays has to be 
processed/filtered to observe the intended correlations between the experimental aims. 
We have shown that in silico predicted protein attributes can play a significant role in optimising 
the design and production of protein constructs. With a larger sample size, we expect the 
aforementioned methods to become more accurate, and therefore call for the establishment of a 
community wide database for sharing both in silico and experimental data so that this can be 
incorporated into a much larger training data set applicable to a variety of biological functions. 
Inspiration came, in part, from the SourceTracker algorithm used in metagenomic studies to track 
possible sources of contamination in HTS studies. This involved establishing a database of known 
contaminants, used by the algorithm to refine the search for contaminant bacteria27 . We hope that 
the establishment of a database of potential test sequences used in other research laboratories, 
combined with their in silico parameters and in the case of those that are synthesised, their 
biological output, would similarly improve the accuracy of the predictions of the F2F-Bridge. To 
expedite the process of database formation we plan to launch a server in the coming months which 
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will take as input an amino acid sequence, and perform all of the necessary calculations, and will 
also accept one or more measures of overall biological function, in the hope that fellow researchers 
will submit their published data. Both linear models (selected with lasso regression) and tree based 
methods (random forest regression trees) can further assist in the prediction of “overall biological 
performance”. With larger datasets, we hope to develop one or more of the following strategies:  
i) A method of applying weights to the features in the F2F-Bridge based on the outputs of the two 
models previously mentioned 
ii) Develop a distinct predictive tool based purely on one or both of these methods 
iii) Design a protocol suited to large scale projects whereby an initial subset of the test sequences 
are generated and screen experimentally and in silico, by the F2F-Bridge itself, or with a 
combination of the three methods outlines in this paper. The resulting information could then be 
fed back into the design protocol to refine this process, increasing the success rate of constructs.  
 
Conclusions The design-build-test-learn approach of synthetic biology stands to benefit 
immensely from this method. Wetlab assays to test multiple test sequences demand a huge amount 
of resources, time and human effort. In such a situation, Function2Form becomes an indispensable 
strategy for a biologist to visualise and improve a given test sequence or to triage potential best 
performers by scoring and ranking the test sequences. Integrating F2F-Bridge into the ‘learn’ step 
aids user empowerment by providing a wetlab biologist with a holistic readout on the overall 
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performance of the protein. With a community-based data reporting system and larger data sets, 
the accuracy of the F2F-Bridge could be tuned to Pareto optimality.   
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Figure legends: 
Figure 1: In silico tools for protein modelling and design.  
 
 
Figure 2: The in silico aided protein design process and the overall performance problem. 
Multiple test sequences are generated for a user-defined overall function (The overall function is 
the collective functioning of all the sub-function parts). Sub-function parts and the test sequence 
build dictate the 3D structure. Test sequences are subjected to in silico modelling and multiple 
analyses. F2F bridge provides an objective, single metric and a calculated output to aid the 
selection of an optimal candidate. 
 
 
Figure 3: 3D structure of the designed luminescence test sequences examined showing various 
sub-function parts for a defined overall function. 
 
 
Figure 4: Workflow of wet lab validation of test sequences. 
 
 
Figure 5: F2F-bridge output for ClfA test sequences. 
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Areas where the candidate protein (pink) does not meet the preset requirements is highlighted by 
contrasting with the coloured region of the reference values (blue).  The plot is generated using a 
bespoke function written in R, and detailed instructions on its use can be found in supplementary 
materials, with a link to the github repository containing the code. 
 
 
Figure 6: Output of F2F Post Hoc Analysis 
(A) shows the graphical output of LASSO features selection for both (i) antiMuc1 and (ii) 
antiClfA test sequences for predicting bound protein luminescence. Each coloured line 
corresponds to a predictive feature used in the F2F-Bridge function. The lines plot the path of 
the variables coefficient against the L1-norm, of the whole coefficient vector as lambda varies. 
Both show that Lasso regression analysis was capable of identifying relationships between the 
examined predictive features, and experimentally determined luminescence. 
(B)(i) shows the same LASSO based feature selection for antiClfA test sequences, using secreted 
luminescence as output.  In this instance, Isoelectric point enters the model first, and Instability 
appears to have the most pronounced effect on the test variable. The relationship between these 
and the experimentally derived luminescence was tested with a multiple linear regression. Both 
features were found to be significant in the model, which explained 84.61% of the variability in 
luminescence, with an associated p-value of 0.004. This allowed us to build a predictive model 
using antiClfA test sequences as the training set. (ii) Shows a correlation plot of luminescence 
values for test sequences predicted by a LASSO directed linear model, vs experimentally derived 
secreted luminescence values. The training set (antiClfA test sequences) is coloured blue, and the 
test set (antiMUC1) is coloured red. 
(C) summarises the Random Forest regression tree analysis. As with (B) the successful model 
was trained on the antiClfA data, and tested on the antiMUC1 data. (i) shows mean node purity 
for each predictive feature. The lower this value, the more important it is to the model.  The 
model, trained on the antiClfA test sequences was able to explain 41% of the variability in 
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experimentally determined secreted luminescence. The model was then used to predict secreted 
luminescence values of the training set (antiClfA) and the test set (antiMUC1), and these 
predicted values were correlated with experimentally derived luminescence values in figure (ii). 
The overall correlation coefficient was 0.87, with an associated p-value of 1e-05, indicating the 
value of the predictive model generated. 
 
 
Figure 7: Correlation plot of OP-Score vs Overall Biological Performance.  
Overall biological performance was scored for fluorescence. Correlation test carried out using 
Spearman’s method.  
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Table Legends: 
Table 1: Common in silico tools, and the purpose they serve  
Table 2: Agreement between experimental results and F2F plot - Luminescence. In both antiMuc1(A) 
and Anti-ClfA(B), the binding affinity of each protein is measured by luminescence output. Proteins are 
ranked by their OP score in both tables, and coloured from green (best performing protein), through yellow, 
to red (worst performing protein) for both luminescence and OP score. (Lowest number = best OP score.) 
Table 3: Results of multiple regression analysis of features selected by Lasso regression analysis against 
experimentally determined luminescence.  
Table 4: Correlation coefficients and associated p-values of LASSO directed linear model based 
predictions of test sequence luminescence, vs experimentally derived results for luminescence.  
Table 5: Results of various predictive models of secreted luminescence generated using 
RandomForest regression trees, when correlated with the lab-generated values.  
Table 6: Summary of statistical tests performed 
Table 7: Agreement between experimental results and F2F plot - Fluorescence. 
Proteins are ranked by their OP score, and coloured from green (best performing protein), through yellow, 
to red (worst performing protein) for both Fluorescence and OP score. (Lowest number = best OP score.) 
Table 8: The two associated workflows of the F2F Bridge. 
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Design Parameter Metric and Scale range Metric description Effect on overall performance Generated: 
3D structure C-score 2 : -5 Confidence in the 
model and folds 
predicted 




Docking ΔG kcal/mol Gibbs free energy 
released by reaction 
Protein-protein interactions at 
the active site predicted 
Autodock 
Vina*29  
Quality of model RC – score   Proportion of amino 
acids in different 
regions based on 
steric hindrance 
High agreement with 
stereochemistry and free energy 
reflects stability of structure 
Saves server30  
Active site solvent 
accessibility  
0-9 A measure of the 
exposure of A 
residue or group of 
residues 
Depending upon the function, 
the active site could be exposed 










-4.5 to +4.5 Each amino acid has 
a hydrophobicity 
score between -4.5 
and +4.5 as per Kyte 
Doolittle scale.  
Ensuring ideal surface 





Size kDa Total weight of the 
protein 
Size forms an important factor if 
the protein is required to 
cross/penetrate membranes and 
biological barriers 
ProtParam 
Hosted by  
Expasy32  
Isoelectric point pH 0 to 14 Point at which 
molecule carries no 
net charge 
The integrity of the structure of 
the protein in a setting is 
influenced by the isoelectric 
point 
ProtParam 
Hosted by  
Expasy32  
Potential active sites 0 to n Number of potential 
active sites 
Predicting the potential active 
sites on the designed protein 




Instability 0 to 100 Half life of protein 
in vitro 
Gives an indication of the 
viability of the protein 
ProtParam 
Hosted by  
Expasy32  
Table 1: Common in silico tools, and the purpose they serve 
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Table 2: Agreement between experimental results and F2F plot - Luminescence. 
In both antiMuc1(A) and Anti-ClfA(B), the binding affinity of each protein is measured by luminescence 
output. Proteins are ranked by their OP score in both tables, and coloured from green (best performing 
protein), through yellow, to red (worst performing protein) for both luminescence and OP score. (Lowest 
number = best OP score.) 
 
  
This article is protected by copyright. All rights reserved.
      
 
      
Test sequences P-Value Adjusted R Squared 
antiClfA 0.507 -.06 
antiMUC1 0.867 -.6 
Table 3: Results of multiple regression analysis of features selected by Lasso regression analysis against 
experimentally determined luminescence.  
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      All antiMuc1 antiClfa 
Rho 0.846 0.71 0.93 
P value 0.0009 0.04 0.0006 
Table 4: Correlation coefficients and associated p-values of LASSO directed linear model based 
predictions of test sequence luminescence, vs experimentally derived results for luminescence.  
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      antiClfA antiMuc1 Total 
P value 0.002 0.05 1e-5 
Rho 0.92 0.71 0.87 
Table 5: Results of various predictive models of secreted luminescence generated using 
RandomForest regression trees, when correlated with the lab-generated values.  
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Summary of methods tested and results: 











The F2F plot was able to provide 
a guide for the expected 
performance of the test sequence 
when the test sequences were 
ranked by OP score and by wet 
lab output, and the accompanying 
plot was able to inform on how to 
improve the test sequence. No 
statistically significant 
relationship between OP score 
and wet lab output could be 
found.  
LASSO feature 
selection and linear 
model building 
Binding antiClfA and 
antiMUC1 
LASSO regression analysis was 
able to detect discrete patterns in 
the data, showing Hydrophobicity 
and Isoelectric point both to have 
a positive relationship with bound 
luminescence in antiClfA. In the 
case of antiMUC1 Docking 
Affinity and Solvent accessibility 
were shown to have a positive 
effect, Isoelectric point and 
Hydrophobicity a negative one.  
Using LASSO 
regression analysis 
dictated linear model as 
a predictive tool 
Binding antiClfA and 
antiMUC1 
The models predicted in the 
above analysis were unable to 
exaplain any of the variability in 
the bound luminescence of 
antiMUC1 or ClfA test 
sequences.  
LASSO feature 
selection and linear 
model building 
Luminescence antiClfA LASSO regression analysis was 
able to detect discrete patterns in 
the data, a linear regression with 
solvent accessibility and 
instability was able to explain 
86.4% of the variability in 
luminescence in the antiClfA 
samples.  
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Using LASSO 
regression analysis 
dictated linear model as 
a predictive tool 
Luminescence antiClfA and 
antiMUC1 
The model created in the above 
test was used to predict 
luminescence values for both 
antiClfA and antiMUC1. In both 
cases these predictions showed 
strong positive correlations with 
the experimental luminescence 
values which were statistically 
significant. 
Random Forest 
regression tree model 
building 
Luminescence antiClfA A regression tree implemented 
with randomForest was able to 
explain ~41% of the variability in 
the luminescence of antiClfA test 
sequences. 
Using Random Forest 
regression tree as a 
predictive tool 
Luminescence antiClfA and 
antiMUC1 
The model created in the above 
test was used to predict 
luminescence values for antiClfA 
and antiMUC1 test sequences. In 
both cases, these predictions 
showed strong positive 
correlations with the 
experimental luminescence 
values that were statistically 
significant. 
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Table 7: Agreement between experimental results and F2F plot - Fluorescence. 
Proteins are ranked by their OP score, and coloured from green (best performing protein), through yellow, 
to red (worst performing protein) for both Fluorescence and OP score. (Lowest number = best OP score.) 
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Table 8: The two associated workflows of the F2F Bridge. 
 
 
Scale of use Outcome 
High Throughput A database of test sequences or extant proteins of 
known sequence can be queried with the F2F-
bridge scoring each test sequence and identifying 
those most suitable. 
Low Throughput On a protein by protein basis the F2F-bridge 
provides a graphical overview of the relationship 
between the features of the test sequence and the 
optimal values specified by the user, informing 
the user on how to improve the test sequence.  
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